Abstract:Background There is an unmet need for new therapeutics to treat Acute Respiratory Distress Syndrome (ARDS), an important cause of morbidity and mortality in critically ill patients. Bone marrow‐derived mesenchymal stromal cells (MSC) attenuate acute lung injury (ALI) in preclinical models of ARDS through secretion of soluble factors into the conditioned media (CM) that act in a paracrine fashion. Keratinocyte growth factor (KGF) is secreted by MSC and mediates several of the beneficial effects in ALI preclinical models. Thus, the objective for this study was to transfect MSC with the KGF gene to enhance the beneficial effects of conditioned media (CM) derived from transfected MSC on endothelial cell permeability and pulmonary vascular injury in hemorrhagic shock. The long term goal of these efforts would be to utilize gene enhanced MSC CM in lieu of MSC. Hypothesis The beneficial effects of MSC CM on pulmonary and systemic vascular permeability can be enhanced through gene modification of MSC with transfection of the KGF gene. Materials and Methods Gene modification of MSC : To modify bone marrow‐derived MSC with a constitutive KGF expressing plasmid, nucleofection was conducted using the Amaxa Nucleofection System (Lonza, MD) and varying doses of KGF plasmid (0.5–3.0 ug). Endothelial Permeability : The integrity of EC (HUVEC) monolayers and trans‐endothelial resistance (TEER) was measured using an electric cell‐substrate impedance sensing system (ECIS) (Applied BioPhysics, Troy, NY). Hemorrhagic Shock (HS) and Trauma model of ARDS: Male C57BL6 mice, 8–12 weeks old were subjected to a 2.5‐cm midline laparotomy. Using an established model of HS, mice were bled to a mean arterial blood pressure of 35 mm Hg for 90 minutes. Mice were resuscitated MSC and MSC CM in 200 ul of saline. Pulmonary vascular permeability was measured using an Alexa Flour dextran 10 kDa injected into the pulmonary artery one hour prior to sacrifice. Results Nucleofection of MSC with KGF plasmid increased protein concentrations of KGF in the CM by 4‐fold. In vitro, KGF modified MSC CM significantly enhanced endothelial monolayer resistance and reduced permeability compared to control MSC CM as measured by ECIS. Area under the curve measurements: CM from control media (0.63 ± 0.011), CM from GFP transfected MSC (0.66 ± 0.0029), CM from mock transfected cells (0.65 ± 0.013) and CM from KGF transfected cells (0.68 ± 0.0076), p<0.05 GFP versus KGF ( Figure ). In vivo, both MSC and KGF enhanced MSC CM demonstrated significant potent effects in attenuating pulmonary vascular permeability induced by HS and trauma with a 35% reduction in accumulation of the 10kDa dextran in the extravascular spaces of mouse lungs compared to controls (P<0.05). Conclusion KGF‐enriched conditioned media from MSC reduces in vitro endothelial permeability and also in vivo lung permeability from hemorrhagic shock. KGF‐enriched conditioned media from MSC may provide an alternative to treat increased lung vascular permeability from acute lung injury. Use of a cell‐free therapeutic may have logistical, safety and regulatory advantages for implementation in patients with ARDS. Support or Funding Information NHLBI UC‐CAI 20130924SFM

The Hepatocyte Growth Factor-Expressing Character is Required for Mesenchymal Stem Cells to Protect the Lung Injured by Lipopolysaccharide in Vivo

The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays A Positive Role in Treatment of Acute Lung Injury in Vivo

Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor

Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats

Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury

Immunosuppressive Effect Of Mesenchymal Stem Cells On Lung And Gut Cd8(+) T Cells In Lipopolysaccharide-Induced Acute Lung Injury In Mice

Mesenchymal Stem Cells Ameliorate LPS-induced Acute Lung Injury Through KGF Promoting Alveolar Fluid Clearance of Alveolar Type II Cells.

Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury

Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury

Hepatocyte Growth Factor Gene-Modified Mesenchymal Stem Cells Reduce Radiation-Induced Lung Injury

Identification and Modulation of Microenvironment is Crucial for Effective MSC Therapy in Acute Lung Injury.

Retraction Note: Overexpression of TGFβ1 in Murine Mesenchymal Stem Cells Improves Lung Inflammation by Impacting the Th17/Treg Balance in LPS-induced ARDS Mice

[The Role and Mechanism of Mesenchymal Stem Cell in Modulating Human Pulmonary Microvascule Endothelial Cell Permeability Via Paracrine Hepatocyte Growth Factor].

Conditioned Media from Keratinocyte Growth Factor Modified Mesenchymal Stromal Cells Reduces Pulmonary Vascular Permeability

Mtor/stat‐3 Pathway Mediates Mesenchymal Stem Cell–secreted Hepatocyte Growth Factor Protective Effects Against Lipopolysaccharide‐induced Vascular Endothelial Barrier Dysfunction and Apoptosis

Effects of different concentrations of mesenchymal stem cells treatment on LPS-induced acute respiratory distress syndrome rat model

Overexpression of TGFβ1 in murine mesenchymal stem cells improves lung inflammation by impacting the Th17/Treg balance in LPS-induced ARDS mice

Lung-resident mesenchymal stem cells regulated the inflammatory responses in innate and adaptive immune cells through HVEM-BTLA pathway during ARDS

Interaction Between Mesenchymal Stem Cells and Endothelial Cells Restores Endothelial Permeability Via Paracrine Hepatocyte Growth Factor in Vitro.

Hepatocyte growth factor protects pulmonary endothelial barrier against oxidative stress and mitochondria-dependent apoptosis

Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury